CH PHARMACONSULTING

Sint-Pieters-Woluwe ·KBO/BCE: BE 0780.468.928

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	88.5%	53.6%	better than 89% of 442 sector peers
Net result	€-28k	€16k	better than 5% of 442 sector peers
Equity	€41k	€38k	better than 52% of 442 sector peers
Gross operating margin	€-6k	€32k	better than 8% of 442 sector peers
Total assets	€46k	€83k	better than 28% of 442 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€46k
Fixed assets	21/28	€585
Financial fixed assets	28	€585
Current assets	29/58	€46k
Amounts receivable within one year	40/41	€43k
Cash & bank	54/58	€2k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€46k
Equity	10/15	€41k
Contributions / capital	10/11	€3k
Accumulated profits (losses)	14	€38k
Amounts payable	17/49	€5k
Amounts payable within one year	42/48	€5k
Trade debts payable within one year	44	€5k
Income statement
Gross operating margin	9900	€-6k
Operating result	9901	€-25k
Financial income	75	€2k
Financial charges	65	€5k
Result before taxes	9903	€-27k
Income taxes	67/77	€291
Net result for the period	9904	€-28k
Result to be appropriated	9905	€-28k

NACE primary	Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg(74999)
Legal form	Private limited company(610)
Incorporation	14-01-2022
Status	Active
Postal code	1150

Summary